{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:40:50Z","timestamp":1787161250834,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiol med"],"DOI":"10.1007\/s11547-025-01954-8","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T10:48:40Z","timestamp":1737370120000},"page":"493-507","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Profile and methodology of ancillary protective measures employed during percutaneous renal cryoablation in a single high-volume centre"],"prefix":"10.1007","volume":"130","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3707-3356","authenticated-orcid":false,"given":"Sinan","family":"Orkut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"De Marini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander Sheng Ming","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Garnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibault","family":"Tricard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto Luigi","family":"Cazzato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshin","family":"Gangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,20]]},"reference":[{"key":"1954_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA A Cancer J Clin 70:7\u201330. https:\/\/doi.org\/10.3322\/caac.21590","journal-title":"CA A Cancer J Clin"},{"key":"1954_CR2","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.eururo.2022.08.019","volume":"82","author":"L Bukavina","year":"2022","unstructured":"Bukavina L, Bensalah K, Bray F et al (2022) Epidemiology of renal cell carcinoma: 2022 update. Eur Urol 82:529\u2013542. https:\/\/doi.org\/10.1016\/j.eururo.2022.08.019","journal-title":"Eur Urol"},{"key":"1954_CR3","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1148\/radiol.2020192325","volume":"296","author":"J Morkos","year":"2020","unstructured":"Morkos J, Porosnicu Rodriguez KA, Zhou A et al (2020) Percutaneous cryoablation for stage 1 renal cell carcinoma: outcomes from a 10-year prospective study and comparison with matched cohorts from the national cancer database. Radiology 296:452\u2013459. https:\/\/doi.org\/10.1148\/radiol.2020192325","journal-title":"Radiology"},{"key":"1954_CR4","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1148\/radiol.2020200149","volume":"296","author":"SK Bhagavatula","year":"2020","unstructured":"Bhagavatula SK, Tuncali K, Shyn PB et al (2020) Percutaneous CT- and MRI-guided cryoablation of cT1 renal cell carcinoma: intermediate- to long-term outcomes in 307 patients. Radiology 296:687\u2013695. https:\/\/doi.org\/10.1148\/radiol.2020200149","journal-title":"Radiology"},{"key":"1954_CR5","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.2214\/AJR.13.11084","volume":"201","author":"X Buy","year":"2013","unstructured":"Buy X, Lang H, Garnon J et al (2013) Percutaneous renal cryoablation: prospective experience treating 120 consecutive tumors. Am J Roentgenol 201:1353\u20131361. https:\/\/doi.org\/10.2214\/AJR.13.11084","journal-title":"Am J Roentgenol"},{"key":"1954_CR6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.urology.2019.08.005","volume":"133","author":"CA Murray","year":"2019","unstructured":"Murray CA, Welch BT, Schmit GD et al (2019) Safety and efficacy of percutaneous image-guided cryoablation of completely endophytic renal masses. Urology 133:151\u2013156. https:\/\/doi.org\/10.1016\/j.urology.2019.08.005","journal-title":"Urology"},{"key":"1954_CR7","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.diii.2021.04.002","volume":"102","author":"P De Marini","year":"2021","unstructured":"De Marini P, Cazzato RL, Garnon J et al (2021) Safety and oncologic efficacy of percutaneous MRI-guided cryoablation of intraparenchymal renal cancers. Diagn Interv Imaging 102:531\u2013538. https:\/\/doi.org\/10.1016\/j.diii.2021.04.002","journal-title":"Diagn Interv Imaging"},{"key":"1954_CR8","doi-asserted-by":"publisher","first-page":"6293","DOI":"10.1007\/s00330-019-06191-y","volume":"29","author":"J Garnon","year":"2019","unstructured":"Garnon J, Van Strijen MJ, Nielsen TK et al (2019) Safety of percutaneous renal cryoablation: an international multicentre experience from the EuRECA retrospective percutaneous database. Eur Radiol 29:6293\u20136299. https:\/\/doi.org\/10.1007\/s00330-019-06191-y","journal-title":"Eur Radiol"},{"key":"1954_CR9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/JU.0000000000001911","volume":"206","author":"SC Campbell","year":"2021","unstructured":"Campbell SC, Clark PE, Chang SS et al (2021) Renal mass and localized renal cancer: evaluation, management, and follow-up: AUA guideline: part I. J Urol 206:199\u2013208. https:\/\/doi.org\/10.1097\/JU.0000000000001911","journal-title":"J Urol"},{"key":"1954_CR10","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.eururo.2022.03.006","volume":"82","author":"B Ljungberg","year":"2022","unstructured":"Ljungberg B, Albiges L, Abu-Ghanem Y et al (2022) European association of urology guidelines on renal cell carcinoma: the 2022 update. Eur Urol 82:399\u2013410. https:\/\/doi.org\/10.1016\/j.eururo.2022.03.006","journal-title":"Eur Urol"},{"key":"1954_CR11","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.jvir.2017.07.013","volume":"28","author":"HD Aoun","year":"2017","unstructured":"Aoun HD, Littrup PJ, Jaber M et al (2017) Percutaneous cryoablation of renal tumors: Is it time for a new paradigm shift? J Vasc Interv Radiol 28:1363\u20131370. https:\/\/doi.org\/10.1016\/j.jvir.2017.07.013","journal-title":"J Vasc Interv Radiol"},{"key":"1954_CR12","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.7150\/jca.28881","volume":"10","author":"W Deng","year":"2019","unstructured":"Deng W, Chen L, Wang Y et al (2019) Cryoablation versus partial nephrectomy for clinical stage T1 renal masses: a systematic review and meta-analysis. J Cancer 10:1226\u20131236. https:\/\/doi.org\/10.7150\/jca.28881","journal-title":"J Cancer"},{"key":"1954_CR13","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1148\/radiol.2018180249","volume":"289","author":"DJ Breen","year":"2018","unstructured":"Breen DJ, King AJ, Patel N et al (2018) Image-guided cryoablation for sporadic renal cell carcinoma: three- and 5-year outcomes in 220 patients with biopsy-proven renal cell carcinoma. Radiology 289:554\u2013561. https:\/\/doi.org\/10.1148\/radiol.2018180249","journal-title":"Radiology"},{"key":"1954_CR14","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1007\/s00270-019-02226-5","volume":"42","author":"AJ Gunn","year":"2019","unstructured":"Gunn AJ, Joe WB, Salei A et al (2019) Percutaneous cryoablation of stage T1b renal cell carcinoma: safety, technical results, and clinical outcomes. Cardiovasc Intervent Radiol 42:970\u2013978. https:\/\/doi.org\/10.1007\/s00270-019-02226-5","journal-title":"Cardiovasc Intervent Radiol"},{"key":"1954_CR15","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1148\/radiol.2018172960","volume":"288","author":"J Uhlig","year":"2018","unstructured":"Uhlig J, Kokabi N, Xing M, Kim HS (2018) Ablation versus resection for stage 1A renal cell carcinoma: national variation in clinical management and selected outcomes. Radiology 288:889\u2013897. https:\/\/doi.org\/10.1148\/radiol.2018172960","journal-title":"Radiology"},{"key":"1954_CR16","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.juro.2016.04.081","volume":"196","author":"PM Pierorazio","year":"2016","unstructured":"Pierorazio PM, Johnson MH, Patel HD et al (2016) Management of renal masses and localized renal cancer: systematic review and meta-analysis. J Urol 196:989\u2013999. https:\/\/doi.org\/10.1016\/j.juro.2016.04.081","journal-title":"J Urol"},{"key":"1954_CR17","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1002\/cncr.23896","volume":"113","author":"DA Kunkle","year":"2008","unstructured":"Kunkle DA, Uzzo RG (2008) Cryoablation or radiofrequency ablation of the small renal mass: a meta-analysis. Cancer 113:2671\u20132680. https:\/\/doi.org\/10.1002\/cncr.23896","journal-title":"Cancer"},{"key":"1954_CR18","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jvir.2006.12.007","volume":"18","author":"PJ Littrup","year":"2007","unstructured":"Littrup PJ, Ahmed A, Aoun HD et al (2007) CT-guided percutaneous cryotherapy of renal masses. J Vasc Interv Radiol 18:383\u2013392. https:\/\/doi.org\/10.1016\/j.jvir.2006.12.007","journal-title":"J Vasc Interv Radiol"},{"key":"1954_CR19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/RLI.0000000000000719","volume":"56","author":"RL Cazzato","year":"2021","unstructured":"Cazzato RL, De Marini P, Leonard-Lorant I et al (2021) Safety and oncologic outcomes of magnetic resonance imaging-guided cryoablation of renal cell carcinoma: a 10-year single-center experience. Invest Radiol 56:153\u2013162. https:\/\/doi.org\/10.1097\/RLI.0000000000000719","journal-title":"Invest Radiol"},{"key":"1954_CR20","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/s00270-018-2089-7","volume":"42","author":"J Garnon","year":"2019","unstructured":"Garnon J, Cazzato RL, Caudrelier J et al (2019) Adjunctive thermoprotection during percutaneous thermal ablation procedures: review of current techniques. Cardiovasc Intervent Radiol 42:344\u2013357. https:\/\/doi.org\/10.1007\/s00270-018-2089-7","journal-title":"Cardiovasc Intervent Radiol"},{"key":"1954_CR21","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1053\/j.tvir.2011.02.009","volume":"14","author":"G Tsoumakidou","year":"2011","unstructured":"Tsoumakidou G, Buy X, Garnon J et al (2011) Percutaneous thermal ablation: how to protect the surrounding organs. Tech Vasc Interv Radiol 14:170\u2013176. https:\/\/doi.org\/10.1053\/j.tvir.2011.02.009","journal-title":"Tech Vasc Interv Radiol"},{"key":"1954_CR22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.clinimag.2017.12.003","volume":"50","author":"F Khan","year":"2018","unstructured":"Khan F, Ho AM, Jamal JE et al (2018) Long-term outcomes after percutaneous renal cryoablation performed with adjunctive techniques. Clin Imaging 50:62\u201367. https:\/\/doi.org\/10.1016\/j.clinimag.2017.12.003","journal-title":"Clin Imaging"},{"key":"1954_CR23","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.jvir.2019.04.017","volume":"30","author":"IJ Patel","year":"2019","unstructured":"Patel IJ, Rahim S, Davidson JC et al (2019) Society of interventional radiology consensus guidelines for the periprocedural management of thrombotic and bleeding risk in patients undergoing percutaneous image-guided interventions\u2014part ii: recommendations. J Vasc Interv Radiol 30:1168-1184.e1. https:\/\/doi.org\/10.1016\/j.jvir.2019.04.017","journal-title":"J Vasc Interv Radiol"},{"key":"1954_CR24","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.juro.2009.05.035","volume":"182","author":"A Kutikov","year":"2009","unstructured":"Kutikov A, Uzzo RG (2009) The renal nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol 182:844\u2013853. https:\/\/doi.org\/10.1016\/j.juro.2009.05.035","journal-title":"J Urol"},{"key":"1954_CR25","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s00270-017-1703-4","volume":"40","author":"DK Filippiadis","year":"2017","unstructured":"Filippiadis DK, Binkert C, Pellerin O et al (2017) Cirse quality assurance document and standards for classification of complications: the cirse classification system. Cardiovasc Intervent Radiol 40:1141\u20131146. https:\/\/doi.org\/10.1007\/s00270-017-1703-4","journal-title":"Cardiovasc Intervent Radiol"},{"key":"1954_CR26","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1007\/s00270-013-0831-8","volume":"37","author":"CS Georgiades","year":"2014","unstructured":"Georgiades CS, Rodriguez R (2014) Efficacy and safety of percutaneous cryoablation for stage 1A\/B renal cell carcinoma: results of a prospective, single-arm, 5-year study. Cardiovasc Intervent Radiol 37:1494\u20131499. https:\/\/doi.org\/10.1007\/s00270-013-0831-8","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"4","key":"1954_CR27","doi-asserted-by":"publisher","first-page":"E181","DOI":"10.1111\/j.1464-410X.2012.11538.x","volume":"111","author":"ML Blute Jr","year":"2013","unstructured":"Blute ML Jr, Okhunov Z, Moreira DM, George AK, Sunday S, Lobko II, Vira MA (2013) Image-guided percutaneous renal cryoablation: preoperative risk factors for recurrence and complications. BJU Int 111(4):E181\u2013E185. https:\/\/doi.org\/10.1111\/j.1464-410X.2012.11538.x","journal-title":"BJU Int"},{"key":"1954_CR28","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.jvir.2019.11.039","volume":"31","author":"JT Marion","year":"2020","unstructured":"Marion JT, Schmitz JJ, Schmit GD et al (2020) Safety and efficacy of retrograde pyeloperfusion for ureteral protection during renal tumor cryoablation. J Vasc Interv Radiol 31:1249\u20131255. https:\/\/doi.org\/10.1016\/j.jvir.2019.11.039","journal-title":"J Vasc Interv Radiol"},{"key":"1954_CR29","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/iju.14013","volume":"26","author":"T Yamagami","year":"2019","unstructured":"Yamagami T, Yoshimatsu R, Kajiwara K et al (2019) Protection from injury of organs adjacent to a renal tumor during percutaneous cryoablation. Int J of Urol 26:785\u2013790. https:\/\/doi.org\/10.1111\/iju.14013","journal-title":"Int J of Urol"},{"key":"1954_CR30","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s00261-020-02760-8","volume":"46","author":"J Weiss","year":"2021","unstructured":"Weiss J, Garnon J, Cazzato RL et al (2021) Percutaneous hydrodissection for thermoprotection during cryoablation of periureteric and pyeloureteric junction renal cell carcinomas. Abdom Radiol 46:1179\u20131187. https:\/\/doi.org\/10.1007\/s00261-020-02760-8","journal-title":"Abdom Radiol"},{"key":"1954_CR31","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/1752-1947-6-365","volume":"6","author":"AI Morgan","year":"2012","unstructured":"Morgan AI, Doble A, Davies RJ (2012) Successful conservative management of a colorenal fistula complicating percutaneous cryoablation of renal tumors: a case report. J Med Case Reports 6:365. https:\/\/doi.org\/10.1186\/1752-1947-6-365","journal-title":"J Med Case Reports"},{"key":"1954_CR32","doi-asserted-by":"publisher","first-page":"106","DOI":"10.4291\/wjgp.v1.i3.106","volume":"1","author":"JD Wysocki","year":"2010","unstructured":"Wysocki JD (2010) Colo-renal fistula: an unusual cause of hematochezia. WJGP 1:106. https:\/\/doi.org\/10.4291\/wjgp.v1.i3.106","journal-title":"WJGP"},{"key":"1954_CR33","doi-asserted-by":"publisher","first-page":"779","DOI":"10.2214\/AJR.08.1570","volume":"194","author":"KD Bodily","year":"2010","unstructured":"Bodily KD, Atwell TD, Mandrekar JN et al (2010) Hydrodisplacement in the percutaneous cryoablation of 50 renal tumors. Am J Roentgenol 194:779\u2013783. https:\/\/doi.org\/10.2214\/AJR.08.1570","journal-title":"Am J Roentgenol"},{"key":"1954_CR34","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s00270-015-1110-7","volume":"39","author":"K Shimizu","year":"2016","unstructured":"Shimizu K, Mogami T, Michimoto K et al (2016) Digestive tract complications of renal cryoablation. Cardiovasc Intervent Radiol 39:122\u2013126. https:\/\/doi.org\/10.1007\/s00270-015-1110-7","journal-title":"Cardiovasc Intervent Radiol"},{"key":"1954_CR35","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1089\/end.2011.0516","volume":"26","author":"SR Patel","year":"2012","unstructured":"Patel SR, Hinshaw JL, Lubner MG et al (2012) Hydrodissection using an Iodinated contrast medium during percutaneous renal cryoablation. J Endourol 26:463\u2013466. https:\/\/doi.org\/10.1089\/end.2011.0516","journal-title":"J Endourol"},{"key":"1954_CR36","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/01.RVI.0000197370.83569.33","volume":"17","author":"TD Atwell","year":"2006","unstructured":"Atwell TD, Wass CT, Charboneau JW et al (2006) Malignant Hypertension during cryoablation of an adrenal gland tumor. J Vasc Interv Radiol 17:573\u2013575. https:\/\/doi.org\/10.1097\/01.RVI.0000197370.83569.33","journal-title":"J Vasc Interv Radiol"}],"container-title":["La radiologia medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-025-01954-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11547-025-01954-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-025-01954-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T00:50:57Z","timestamp":1744937457000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11547-025-01954-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,20]]},"references-count":36,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["1954"],"URL":"https:\/\/doi.org\/10.1007\/s11547-025-01954-8","relation":{},"ISSN":["1826-6983"],"issn-type":[{"value":"1826-6983","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,20]]},"assertion":[{"value":"21 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Roberto Luigi CAZZATO, Julien GARNON, and Afshin GANGI received consultancy fees from Boston Scientific.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Institutional Review Board approval was obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}